glp-1 receptor agonist examples agonists for individualized treatment of type 2 diabetes mellitus Discovery of GLP-1–Based Drugs for
Description
Cell Res
It is noteworthy that this superior effectiveness extended to primates (humans and cynomolgus monkeys) and rodent models of obesity and diabetes, such as db/db (diabetic) mice and Zucker diabetic fatty (ZDF) rat
Censoring and outcome events were identified by the follow-up interval in which they occurred
The main differences across comparison categories are: Mechanism of Action: advantage goes to Retatrutide
Rising patient awareness and improving affordability also contribute to expanding GLP-1 drug uptake
